Background and Aims: The immune system plays vital roles in hepatocellular carcinoma (HCC) initiation and pro-gression. The present study aimed to construct an immune-gene related prognostic signature (IRPS) for predicting the prognosis of HCC patients. Methods: Gene expression data were retrieved from The Cancer Genome Atlas database. The IRPS was established via least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression analysis. The prognostic values of the IRPS were further validated using the International Cancer Genome Consor-tium (ICGC) dataset. Results: A total of 62 genes were identified as candidate immune-related prognostic genes. According to the results of Lasso and multivariate Cox regression analysis, we established an IRPS and confirmed its stability and reliability in the ICGC dataset. The IRPS was significantly associated with advanced clinicopathological characteristics. Both Cox regression analyses revealed that the IRPS could be independent risk factors influencing prognosis of HCC patients. The relationships between the IRPS and infiltration of immune cells demonstrated that the IRPS was associated with immune cell infiltration. Furthermore, a nomogram was constructed to estimate the survival proba-bility of HCC patients. Conclusions: The IRPS was effective for predicting prognosis of HCC patients, which might serve as novel prognostic and therapeutic biomarkers for HCC.
CITATION STYLE
Xia, X., Tang, P., Liu, H., & Li, Y. (2021). Identification and validation of an immune-related prognostic signature for hepatocellular carcinoma. Journal of Clinical and Translational Hepatology, 9(6), 798–808. https://doi.org/10.14218/JCTH.2021.00017
Mendeley helps you to discover research relevant for your work.